Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8125)
All Articles published online
|
Publishing Process of This Article
|
Nov 7, 2018 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Schizas D, Mastoraki A, Naar L, Spartalis E, Tsilimigras DI, Karachaliou GS, Bagias G, Moris D. Concept of histone deacetylases in cancer: Reflections on esophageal carcinogenesis and treatment. World J Gastroenterol 2018; 24(41): 4635-4642 [PMID: 30416311 DOI: 10.3748/wjg.v24.i41.4635] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i41/4635.htm |
| Number | Citing Articles |
| 1 |
·木明 阿力木江. Non Coding RNA Participates in Epigenetic Modification of Esophageal Cancer. Advances in Clinical Medicine 2024; 14(02): 3737 doi: 10.12677/ACM.2024.142521
|
| 2 |
Yuhang Xiao, Min Su, Wei Ou, Hui Wang, Bo Tian, Junliang Ma, Jinming Tang, Jie Wu, Zhining Wu, Wenxiang Wang, Yong Zhou. Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer. Biomedicine & Pharmacotherapy 2019; 117: 109192 doi: 10.1016/j.biopha.2019.109192
|
| 3 |
Eleftherios Spartalis, Konstantinos Kotrotsios, Dimosthenis Chrysikos, Michael Spartalis, Stavroula A. Paschou, Dimitrios Schizas, Konstantinos Tsamakis, Dimitrios Dimitroulis, Theodore Troupis, Nikolaos Nikiteas. Histone Deacetylase Inhibitors and Papillary Thyroid Cancer. Current Pharmaceutical Design 2021; 27(18): 2199 doi: 10.2174/1381612826666201211112234
|
| 4 |
Parul Ahuja, Ritu Yadav, Sandeep Goyal, Chetna Yadav, Shalu Ranga, Lokesh Kadian. Targeting epigenetic deregulations for the management of esophageal carcinoma: recent advances and emerging approaches. Cell Biology and Toxicology 2023; 39(6): 2437 doi: 10.1007/s10565-023-09818-5
|
| 5 |
Hari Krishna Namballa, Pratibha Anchi, Kesari Lakshmi Manasa, Jay Prakash Soni, Chandraiah Godugu, Nagula Shankaraiah, Ahmed Kamal. β-Carboline tethered cinnamoyl 2-aminobenzamides as class I selective HDAC inhibitors: Design, synthesis, biological activities and modelling studies. Bioorganic Chemistry 2021; 117: 105461 doi: 10.1016/j.bioorg.2021.105461
|
| 6 |
Nan Huang, Chang Xu, Liang Deng, Xue Li, Zhixuan Bian, Yue Zhang, Shuping Long, Yan Chen, Ni Zhen, Guohui Li, Fenyong Sun. PAICS contributes to gastric carcinogenesis and participates in DNA damage response by interacting with histone deacetylase 1/2. Cell Death & Disease 2020; 11(7) doi: 10.1038/s41419-020-2708-5
|
| 7 |
Zan Li, Qiuxue Wu, Zhenzhen Wei, Yuli Zhang, Bin Han, Sailei Jia, Hua Sui, Qingfeng Tang. The ZuoJinWan formula inhibits glycolysis of cisplatin resistant gastric cancer cells via p53 acetylation. Pharmacological Research - Modern Chinese Medicine 2024; 10: 100347 doi: 10.1016/j.prmcm.2023.100347
|
| 8 |
Asma Sindhoo Nangraj, Gurudeeban Selvaraj, Satyavani Kaliamurthi, Aman Chandra Kaushik, William C. Cho, Dong Qing Wei. Integrated PPI- and WGCNA-Retrieval of Hub Gene Signatures Shared Between Barrett's Esophagus and Esophageal Adenocarcinoma. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00881
|
| 9 |
Aikaterini Mastoraki, Dimitrios Schizas, Pigi Vlachou, Nikoleta Maria Melissaridou, Nikolaos Charalampakis, Rodanthi Fioretzaki, Christo Kole, Olga Savvidou, Pantelis Vassiliu, Emmanouil Pikoulis. Assessment of Synergistic Contribution of Histone Deacetylases in Prognosis and Therapeutic Management of Sarcoma. Molecular Diagnosis & Therapy 2020; 24(5): 557 doi: 10.1007/s40291-020-00487-2
|
| 10 |
Jiang‐Hu Huang, Yang Xu, Fei‐Yue Lin. The inhibition of microRNA‐326 by SP1/HDAC1 contributes to proliferation and metastasis of osteosarcoma through promoting SMO expression. Journal of Cellular and Molecular Medicine 2020; 24(18): 10876 doi: 10.1111/jcmm.15716
|
| 11 |
Lyu Weidong, Luca Sanna, Valentina Bordoni, Zeng Tiansheng, Li Chengxun, Gabriele Murineddu, Gerard A. Pinna, David J. Kelvin, Luigi Bagella. Target identification of a novel unsymmetrical 1,3,4‐oxadiazole derivative with antiproliferative properties. Journal of Cellular Physiology 2021; 236(5): 3789 doi: 10.1002/jcp.30120
|
| 12 |
Pelin Ergun, Sezgi Kipcak, Serhat Bor. Epigenetic Alterations from Barrett’s Esophagus to Esophageal Adenocarcinoma. International Journal of Molecular Sciences 2023; 24(9): 7817 doi: 10.3390/ijms24097817
|
| 13 |
Dimitrios Schizas, Aikaterini Mastoraki, Leon Naar, Diamantis I. Tsilimigras, Ioannis Katsaros, Vasiliki Fragkiadaki, Georgia-Sofia Karachaliou, Nikolaos Arkadopoulos, Theodore Liakakos, Dimitrios Moris. Histone Deacetylases (HDACs) in Gastric Cancer: An Update of their Emerging Prognostic and Therapeutic Role. Current Medicinal Chemistry 2020; 27(36): 6099 doi: 10.2174/0929867326666190712160842
|
| 14 |
Yang Shi, Zheng Xiang, Huiyu Yang, Suliman Khan, Ruizhe Li, Siran Zhou, Saif Ullah, Jiyu Zhang, Bingrong Liu. Pharmacological targeting of TNS3 with histone deacetylase inhibitor as a therapeutic strategy in esophageal squamous cell carcinoma. Aging 2021; 13(11): 15336 doi: 10.18632/aging.203091
|
| 15 |
Huiwu Li, Hui Li, Yibulayin Waresijiang, Yan Chen, Ying Li, Liang Yu, Yike Li, Ling Liu. Clinical significance of HDAC1, -2 and -3 expression levels in esophageal squamous cell carcinoma. Experimental and Therapeutic Medicine 2020; 20(1): 315 doi: 10.3892/etm.2020.8697
|
| 16 |
Long Liao, Zi‐Ting Yao, Wang‐Kai Fang, Qing‐Yu He, Wen Wen Xu, Bin Li. Epigenetics in Esophageal Cancer: From Mechanisms to Therapeutics. Small Methods 2020; 4(10) doi: 10.1002/smtd.202000391
|
| 17 |
Jindong Li, Chengyan Jin, Lihua Sun, Bin Wang, Peiyan Hua, Yan Zhang. HDAC2 enhances esophageal squamous cell carcinoma development through down-regulating microRNA-503-5p and promoting CXCL10. Clinical Epigenetics 2021; 13(1) doi: 10.1186/s13148-021-01068-8
|
| 18 |
Ksenia S. Maslyonkina, Alexandra K. Konyukova, Darya Y. Alexeeva, Mikhail Y. Sinelnikov, Liudmila M. Mikhaleva. Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression. Cancer Medicine 2022; 11(2): 447 doi: 10.1002/cam4.4447
|
| 19 |
Gang Liu, Haiying Chen, Hua Liu, Wenbo Zhang, Jia Zhou. Emerging roles of SIRT6 in human diseases and its modulators. Medicinal Research Reviews 2021; 41(2): 1089 doi: 10.1002/med.21753
|
| 20 |
Nikolaos Garmpis, Christos Damaskos, Anna Garmpi, Vasiliki E. Georgakopoulou, Panagiotis Sarantis, Efstathios A. Antoniou, Michalis V. Karamouzis, Afroditi Nonni, Dimitrios Schizas, Evangelos Diamantis, Evangelos Koustas, Paraskevi Farmaki, Athanasios Syllaios, Alexandros Patsouras, Konstantinos Kontzoglou, Nikolaos Trakas, Dimitrios Dimitroulis. Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities. Journal of Personalized Medicine 2021; 11(3): 223 doi: 10.3390/jpm11030223
|
| 21 |
Dimitrios Goutas, Stamatios Theocharis, Gerasimos Tsourouflis. Unraveling the Epigenetic Role and Clinical Impact of Histone Deacetylases in Neoplasia. Diagnostics 2021; 11(8): 1346 doi: 10.3390/diagnostics11081346
|
| 22 |
Aikaterini Mastoraki, Dimitrios Schizas, Nikolaos Charalampakis, Leon Naar, Maria Ioannidi, Diamantis Tsilimigras, Maria Sotiropoulou, Dimitrios Moris, Pantelis Vassiliu, Evangelos Felekouras. Contribution of Histone Deacetylases in Prognosis and Therapeutic Management of Cholangiocarcinoma. Molecular Diagnosis & Therapy 2020; 24(2): 175 doi: 10.1007/s40291-020-00454-x
|
| 23 |
Huifang Shi, Weigang Cui, Yan Qin, Lei Chen, Tao Yu, Jie Lv. A glimpse into novel acylations and their emerging role in regulating cancer metastasis. Cellular and Molecular Life Sciences 2024; 81(1) doi: 10.1007/s00018-023-05104-z
|